EcoDrugPlus

Ensembl ID : ENSACIG00000007310
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSACIG00000003702
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSACIG00000015940
Gene Symbol: RPS3A
2 Cross references
372 Possible Orthologues:

Ensembl ID : ENSACIG00000003771
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSACIG00000017249
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSACIG00000001965
Gene Symbol: -
1 Cross references
273 Possible Orthologues:

Ensembl ID : ENSACIG00000001786
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSACIG00000001741
Gene Symbol: -
1 Cross references
270 Possible Orthologues:

Ensembl ID : ENSACIG00000001394
Gene Symbol: RXRAA
1 Cross references
231 Possible Orthologues:

Ensembl ID : ENSACIG00000000373
Gene Symbol: -
Cross references: -
266 Possible Orthologues:

Ensembl ID : ENSACIG00000018415
Gene Symbol: -
Cross references: -
278 Possible Orthologues:

Ensembl ID : ENSACIG00000018408
Gene Symbol: -
Cross references: -
278 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).